{"pub": "dailymail", "url": "https://dailymail.co.uk/money/markets/article-7518337/Woodford-spotlight-Patient-Capital-trust-announces-half-results.html", "downloaded_at": "2019-10-05 06:59:15.841955+00:00", "title": "Woodford at risk of the axe as Patient Capital shrinks 25%", "language": "en", "text": "Fallen fund manager Neil Woodford is facing the axe from the Patient Capital trust that bears his name, as it emerged the value of its assets have tumbled by more than a quarter in the past six months.\n\nIn Woodford Patient Capital Trust's half-year update, the 59-year old, who has been seriously testing investors' patience, told shareholders he was 'very sorry' about the 'extremely disappointing' period.\n\nThe fund manager, whose flagship Equity Income Fund is currently frozen insisted on that his long-term investing approach would eventually pay off.\n\nHowever, the board of the Patient Capital trust, which has seen shares lose 55 per cent of their value since launch, reiterated that they are 'talking to other potential managers' to replace Woodford.\n\n'Very sorry': But Neil Woodford insisted he is committed to his long-term investing approach\n\nThe net asset value of Patient Capital fell by 26 per cent to \u00a3654million in the first six months of the financial year, following a series of writedowns in the value of some of its holdings.\n\nMeanwhile, the trust's share price is trading at a huge 32.3 per cent discount to that 65p per share net asset value as sour sentiment has left investors shunning it.\n\nPatient Capital is separate from Woodford's flagship Equity Income fund, which has been gated since June 3, preventing savers from withdrawing their cash.\n\nBut the crisis at Equity Income has spread to Patient Capital amid investor fears that Woodford has lost his golden touch.\n\nShares in Patient Capital have halved in value since January, after a dip today they rose 2.2 per cent on the day.\n\n'Shareholders have endured an extremely disappointing six-month period, for which I am very sorry,' said Woodford.\n\n'While shareholders can be forgiven for thinking there are no positives, I continue to believe that the majority of the businesses we have invested in are making good progress, in line with our pre-agreed milestones.'\n\nLooking at the performance of the stocks the trust invests in, he conceded that pharma businesses Immunocore and Benevolent AI have seen their values fall, but remained positive for their future.\n\nMeanwhile, Precision Biopsy and Scifluor Life Sciences were written down significantly, 'as it became clear that the funding options that both businesses had been pursuing were unlikely to come to fruition'.\n\nWoodford has been criticised for collecting \u00a37.8million in fees since savers were frozen out from his flagship Equity Income fund.\n\nShares in Patient Capital have halved in value since January to around 43p today\n\n'The Board continues to evaluate the position of the Portfolio Manager and, as previously announced, is talking to other potential managers,' said Susan Searle, chairman of Patient Capital.\n\n'This process can take time and ultimately the Board's decision will be that which is in the best interests of protecting long-term value for shareholders.'\n\nPatient Capital, which was was demoted from the FTSE 250 index earlier this month, was set up in April 2015.\n\nAt the time, it raised \u00a3800million, making it the UK's largest-ever investment trust launch.", "description": "In Woodford Patient Capital Trust's half-year update, the manager, who has been seriously testing investors' patience, told shareholders he was 'very sorry' about the 'extremely disappointing' period.", "authors": ["City", "Finance Reporter For The Daily Mail", "Camilla Canocchi For Thisismoney.Co.Uk", "Some Links In This Article May Be Affiliate Links. If You Click On Them We May Earn A Small Commission. That Helps Us Fund This Is Money", "Keep It Free To Use. We Do Not Write Articles To Promote Products. We Do Not Allow Any Commercial Relationship To Affect Our Editorial Independence."], "top_image": "https://i.dailymail.co.uk/1s/2019/09/29/20/19053750-0-image-a-15_1569786348539.jpg", "published_at": "2019-09-29"}